# In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.

> **NCT03998852** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Bordeaux** · enrollment: 30 (estimated)

## Conditions studied

- Apathy

## Interventions

- **DRUG:** Positron Emission Tomography (PET) with [18F]-FDOPA
- **DRUG:** Positron Emission Tomography (PET) with [18F]-FEOBV
- **DEVICE:** Magnetic Resonnance Imaging (MRI)
- **OTHER:** Neuropsychological evaluation

## Key facts

- **NCT ID:** NCT03998852
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-13
- **Primary completion:** 2022-04-13
- **Final completion:** 2022-05-13
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998852, "In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03998852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*